PLANTATION, Fla., Sept. 28, 2005 (PRIMEZONE) -- MEDirect Latino Inc. (Pink Sheets:MLTO) (http://www.medirectlatino.org) today, announced senior management will attend the Medtrade Conference & Exposition, October 17-20, 2005 at the Georgia World Congress Center to finalize agreements to distribute additional products to the company's growing Hispanic Medicare customer database. The company's product extension goals focus on products which complement its existing line of branded and co-branded diabetic diagnostic testing supplies in the Medicare reimbursable regime, which offer natural extensions and enhance the quality of life of its customers. In addition, the company will complete discussions with international manufacturers and distributors to initiate commercial distribution of its branded line of culturally specific diabetic care products into Mexico, Central, and South America.
MEDirect Latino will build on its initial line of culturally friendly, demographically targeted, co-branded diabetic diagnostic testing supplies with the introduction of additional products and services that are natural health care extensions targeting diabetes and the associated afflictions. The company's two product extensions beyond diabetic supplies, heating pads designed for diabetics and chairlifts to improve the mobility of diabetic customers, have been very well received, with approximately 64 percent of the company's clients ordering these products in addition to their normal diabetic testing products. The company will announce its operating results for September at 4:05 p.m. eastern time on October 10, 2005.
MEDirect Latino Inc. general operations manager, Mr. William Van Aalten, stated, "I have been in the health care reimbursement industry for over 30 years, and MEDirect Latino continues to define the relationship between patient and provider. We listen to our customers and focus our product line extensions that fulfill their needs. I am excited to carry the MEDirect banner at Medtrade this year and fill in our reimbursement tree with those products that improve the quality of life of our customers. As the national media campaign builds, the company has been requested by our customers and their attending physicians to continue to add products to our existing lines. Our goal is to add one new product extension every 60 days."
Mr. Van Aalten added, "We have been pleasantly surprised by the recognition that MEDirect has received by those manufacturers who believe as we do, that the Hispanic Medicare reimbursement market has been totally underserved in the past and now represents the fastest growing segment of the Medicare market. Our schedule is filling up with pharmaceutical companies and product manufacturers desiring to present their products to MEDirect Latino for consideration into our growing database of Hispanic customers.
Additional company information may be obtained by reviewing a detailed analytical profile generated by small cap analyst, Mr. Gerald Kieft, president of Wall Street Resources, Inc., which has upgraded the short-term price target of MLTO to $11.25 per share. This report is an update of the original report issued on May 16, 2005, where Wall Street Resources issued a 12-month target value of $8.40 per share. The increase in valuation is due to the recent reported results of the company, its increasing sales and shipping volume, and diversification of its products and services, which has resulted in a higher initial order value per new client. The 27-page report includes detailed information on the company's business model, products, industry, valuation, management, and risks.
The free report is available at: http://www.wallstreetresources.net/pdf/fc/MLTO2.pdf
About MEDirect Latino:
MEDirect Latino is a rapidly growing, uniquely positioned provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. MEDirect is the only company positioned to serve the U.S. Hispanic health care market as a direct-to-consumer Medicare provider on an authentically national level. The company's current focus is the distribution of products for the treatment of Type II diabetes, specifically because of its disproportionate impact and increasing diagnosis rate within the U.S. Hispanic population, noting an incidence of 120 percent higher than among non-Hispanic whites. Type II diabetes was also targeted because of its unique status within the Medicare reimbursement regime and because of its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These other conditions represent considerable future market potential that will allow MEDirect to efficiently scale its model by leveraging its existing client base and infrastructure.
The current Hispanic market for MEDirect's products is conservatively estimated at approximately $748 million in the continental United States. The size of the opportunity is understated by such figures as an estimated 1.2 million of the over 4.1 million Hispanics in the United States over 65 eligible to receive Medicare benefits are currently collecting these benefits with an estimate that over 1.4 million of those Medicare-eligible Hispanics have diabetes (implying a potential continental U.S. market for MEDirect products of approximately $1 billion).
The MEDirect Latino Inc. logo is available at: http://www.primezone.com/newsroom/prs/?pkgid= 1873
About Medtrade Conference & Exposition: October 18-20, 2005 -- Atlanta, Georgia
Medtrade is established as the premier event for thousands of providers, manufacturers, and industry leaders in home health care. The Medtrade home care community is made up of providers big and small, to plot strategies, find solutions, and explore new techniques and technologies to help businesses succeed. Medtrade offers a marketplace of over 900 exhibiting companies showcasing 297,000-net-square-feet of products and services. This industry-leading event draws over 20,000 industry professionals from across the United States and around the world.
Forward-Looking Statements:
Statements about the company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as the term is defined in the Private Litigation Reform Act of 1995. The company's actual results could differ materially from expected results. The company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Should events occur which materially affect any comments made within this press release, the company will appropriately inform the public.